Abstract
Anti-tachycardia pacing (ATP) is frequently used to terminate ventricular tachycardia (VT), however it is not always successful and may accelerate VT requiring defibrillation. REVRAMP is a novel concept of ATP that involves delivering pacing at a faster rate than VT, but instead of abruptly terminating pacing after eight beats, pacing is gradually slowed until VT continues or normal rhythm is restored. In a pilot study we show that REVRAMP can restore normal rhythm, and that if REVRAMP is unsuccessful, VT is not accelerated.
Original language | English |
---|---|
Pages (from-to) | 54-57 |
Number of pages | 4 |
Journal | Indian Pacing and Electrophysiology Journal |
Volume | 22 |
Issue number | 1 |
Early online date | 12 Nov 2021 |
DOIs | |
Publication status | Published - 28 Jan 2022 |
Bibliographical note
Copyright © 2022 Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Keywords
- Anti tachycardia pacing
- Implantable defribrillator
- Painless therapy